Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Louis Wing Cheong Liu
Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation in Adults
Clinical Medicine Insights: Gastroenterology
Gastroenterology
Related publications
Prescribing Patterns for Outpatient Treatment of Constipation, Irritable Bowel Syndrome-Related Constipation, and Opioid-Induced Constipation: A Retrospective Cross-Sectional Study
Journal of managed care & specialty pharmacy
Health Policy
Pharmacy
Pharmaceutical Science
Clinical and Experimental Study on Probiotics in the Treatment of Constipation Type Irritable Bowel Syndrome
Biomarkers and Applications
Pgi8 - Systematic Literature Review and Indirect Treatment Comparison of Linaclotide Versus Other Oral Constipation Treatments in Patients With Chronic Constipation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
American Journal of Gastroenterology
Hepatology
Gastroenterology
PTU-152 Significant Improvements in Abdominal Pain and Bowel Symptoms in a Phase 3 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A European Perspective
Gut
Gastroenterology
Irritable Bowel Syndrome Subtype Screening Characteristics: Constipation Subtype Patient Profiles Explored
Gastroenterology Insights
Hepatology
Gastroenterology
Pgi46 - Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (Dibss-C)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Response to Linaclotide at Week 4 Predicts Sustained Response in Irritable Bowel Syndrome With Constipation and Improvements in Digestive and Extra-Digestive Symptoms
Therapeutic Advances in Gastroenterology
Gastroenterology
PWE-026 Effects of 26 Weeks of Linaclotide Treatment on Adequate Relief and IBS Severity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): Abstract PWE-026 Table
Gut
Gastroenterology
